NF-1 has been described as the third most common mutated TSG seen within those who develop cutaneous melanoma, and once more, loss of NF-1 leads to increased signaling within the MAPK and PI3K pathways due to hyperactivation of the NRAS protein [110,112]. The gene discussed is NRAS; the disease is cutaneous melanoma.